Arkolith/Insider Trading/DFFN/Form 4

Hollingsworth Jane H

DirectorDiffusion Pharmaceuticals Inc. (DFFN) · full profile →Form 4 · filed May 17, 2021
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2021Buy(P)33K$0.61$20K33K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-21-012537) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML